The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
The global Generic Drugs market was valued at US$ 313470 million in 2023 and is anticipated to reach US$ 551330 million by 2030, witnessing a CAGR of 8.3% during the forecast period 2024-2030.
Market competition is not intense. Teva, Novartis – Sandoz, Mylan, Sun Pharmaceutical and Aspen are the leaders of the industry, with about 19% market shares.
North America is the largest consumption place, with a consumption market share nearly 44%. Following North America, Europe is the second largest consumption place with the consumption market share of 18%.
This report aims to provide a comprehensive presentation of the global market for Generic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Drugs.
Report Scope
The Generic Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Generic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Generic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
- Teva
- Novartis
- Viatris
- Sun Pharmaceutical
- Aspen Pharmacare
- Fresenius Kabi
- Sanofi
- Aurobindo
- Lupin
- Dr. Reddy's
- Apotex
- Cipla
- ENDO
- Stada Arzneimittel
- Bausch Health
- Hikma
- Torrent
- Glenmark
- Piramal Pharma
- Sawai Pharmaceutical
Segment by Type
- Oral
- Injection
- Other
Segment by Application
- Hospital Pharmacy
- Retail Pharmacy
- Other
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina, Colombia)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Generic Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generic Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Injection
1.2.4 Other
1.3 Market by Application
1.3.1 Global Generic Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Generic Drugs Market Perspective (2019-2030)
2.2 Generic Drugs Growth Trends by Region
2.2.1 Global Generic Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Generic Drugs Historic Market Size by Region (2019-2024)
2.2.3 Generic Drugs Forecasted Market Size by Region (2025-2030)
2.3 Generic Drugs Market Dynamics
2.3.1 Generic Drugs Industry Trends
2.3.2 Generic Drugs Market Drivers
2.3.3 Generic Drugs Market Challenges
2.3.4 Generic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Generic Drugs Players by Revenue
3.1.1 Global Top Generic Drugs Players by Revenue (2019-2024)
3.1.2 Global Generic Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Generic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Generic Drugs Revenue
3.4 Global Generic Drugs Market Concentration Ratio
3.4.1 Global Generic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generic Drugs Revenue in 2023
3.5 Generic Drugs Key Players Head office and Area Served
3.6 Key Players Generic Drugs Product Solution and Service
3.7 Date of Enter into Generic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Drugs Breakdown Data by Type
4.1 Global Generic Drugs Historic Market Size by Type (2019-2024)
4.2 Global Generic Drugs Forecasted Market Size by Type (2025-2030)
5 Generic Drugs Breakdown Data by Application
5.1 Global Generic Drugs Historic Market Size by Application (2019-2024)
5.2 Global Generic Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Generic Drugs Market Size (2019-2030)
6.2 North America Generic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Generic Drugs Market Size by Country (2019-2024)
6.4 North America Generic Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Generic Drugs Market Size (2019-2030)
7.2 Europe Generic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Generic Drugs Market Size by Country (2019-2024)
7.4 Europe Generic Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Generic Drugs Market Size (2019-2030)
8.2 Asia-Pacific Generic Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Generic Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Generic Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Generic Drugs Market Size (2019-2030)
9.2 Latin America Generic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Generic Drugs Market Size by Country (2019-2024)
9.4 Latin America Generic Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Generic Drugs Market Size (2019-2030)
10.2 Middle East & Africa Generic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Generic Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Generic Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Detail
11.1.2 Teva Business Overview
11.1.3 Teva Generic Drugs Introduction
11.1.4 Teva Revenue in Generic Drugs Business (2019-2024)
11.1.5 Teva Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Generic Drugs Introduction
11.2.4 Novartis Revenue in Generic Drugs Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Viatris
11.3.1 Viatris Company Detail
11.3.2 Viatris Business Overview
11.3.3 Viatris Generic Drugs Introduction
11.3.4 Viatris Revenue in Generic Drugs Business (2019-2024)
11.3.5 Viatris Recent Development
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Detail
11.4.2 Sun Pharmaceutical Business Overview
11.4.3 Sun Pharmaceutical Generic Drugs Introduction
11.4.4 Sun Pharmaceutical Revenue in Generic Drugs Business (2019-2024)
11.4.5 Sun Pharmaceutical Recent Development
11.5 Aspen Pharmacare
11.5.1 Aspen Pharmacare Company Detail
11.5.2 Aspen Pharmacare Business Overview
11.5.3 Aspen Pharmacare Generic Drugs Introduction
11.5.4 Aspen Pharmacare Revenue in Generic Drugs Business (2019-2024)
11.5.5 Aspen Pharmacare Recent Development
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Detail
11.6.2 Fresenius Kabi Business Overview
11.6.3 Fresenius Kabi Generic Drugs Introduction
11.6.4 Fresenius Kabi Revenue in Generic Drugs Business (2019-2024)
11.6.5 Fresenius Kabi Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Generic Drugs Introduction
11.7.4 Sanofi Revenue in Generic Drugs Business (2019-2024)
11.7.5 Sanofi Recent Development
11.8 Aurobindo
11.8.1 Aurobindo Company Detail
11.8.2 Aurobindo Business Overview
11.8.3 Aurobindo Generic Drugs Introduction
11.8.4 Aurobindo Revenue in Generic Drugs Business (2019-2024)
11.8.5 Aurobindo Recent Development
11.9 Lupin
11.9.1 Lupin Company Detail
11.9.2 Lupin Business Overview
11.9.3 Lupin Generic Drugs Introduction
11.9.4 Lupin Revenue in Generic Drugs Business (2019-2024)
11.9.5 Lupin Recent Development
11.10 Dr. Reddy's
11.10.1 Dr. Reddy's Company Detail
11.10.2 Dr. Reddy's Business Overview
11.10.3 Dr. Reddy's Generic Drugs Introduction
11.10.4 Dr. Reddy's Revenue in Generic Drugs Business (2019-2024)
11.10.5 Dr. Reddy's Recent Development
11.11 Apotex
11.11.1 Apotex Company Detail
11.11.2 Apotex Business Overview
11.11.3 Apotex Generic Drugs Introduction
11.11.4 Apotex Revenue in Generic Drugs Business (2019-2024)
11.11.5 Apotex Recent Development
11.12 Cipla
11.12.1 Cipla Company Detail
11.12.2 Cipla Business Overview
11.12.3 Cipla Generic Drugs Introduction
11.12.4 Cipla Revenue in Generic Drugs Business (2019-2024)
11.12.5 Cipla Recent Development
11.13 ENDO
11.13.1 ENDO Company Detail
11.13.2 ENDO Business Overview
11.13.3 ENDO Generic Drugs Introduction
11.13.4 ENDO Revenue in Generic Drugs Business (2019-2024)
11.13.5 ENDO Recent Development
11.14 Stada Arzneimittel
11.14.1 Stada Arzneimittel Company Detail
11.14.2 Stada Arzneimittel Business Overview
11.14.3 Stada Arzneimittel Generic Drugs Introduction
11.14.4 Stada Arzneimittel Revenue in Generic Drugs Business (2019-2024)
11.14.5 Stada Arzneimittel Recent Development
11.15 Bausch Health
11.15.1 Bausch Health Company Detail
11.15.2 Bausch Health Business Overview
11.15.3 Bausch Health Generic Drugs Introduction
11.15.4 Bausch Health Revenue in Generic Drugs Business (2019-2024)
11.15.5 Bausch Health Recent Development
11.16 Hikma
11.16.1 Hikma Company Detail
11.16.2 Hikma Business Overview
11.16.3 Hikma Generic Drugs Introduction
11.16.4 Hikma Revenue in Generic Drugs Business (2019-2024)
11.16.5 Hikma Recent Development
11.17 Torrent
11.17.1 Torrent Company Detail
11.17.2 Torrent Business Overview
11.17.3 Torrent Generic Drugs Introduction
11.17.4 Torrent Revenue in Generic Drugs Business (2019-2024)
11.17.5 Torrent Recent Development
11.18 Glenmark
11.18.1 Glenmark Company Detail
11.18.2 Glenmark Business Overview
11.18.3 Glenmark Generic Drugs Introduction
11.18.4 Glenmark Revenue in Generic Drugs Business (2019-2024)
11.18.5 Glenmark Recent Development
11.19 Piramal Pharma
11.19.1 Piramal Pharma Company Detail
11.19.2 Piramal Pharma Business Overview
11.19.3 Piramal Pharma Generic Drugs Introduction
11.19.4 Piramal Pharma Revenue in Generic Drugs Business (2019-2024)
11.19.5 Piramal Pharma Recent Development
11.20 Sawai Pharmaceutical
11.20.1 Sawai Pharmaceutical Company Detail
11.20.2 Sawai Pharmaceutical Business Overview
11.20.3 Sawai Pharmaceutical Generic Drugs Introduction
11.20.4 Sawai Pharmaceutical Revenue in Generic Drugs Business (2019-2024)
11.20.5 Sawai Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
